Cipla Q3 PAT dips 2.6 per cent at Rs 729 crore : Rashtra News #Cipla #PAT #dips #cent #crore The Mumbai-based company had posted a consolidated profit after tax (PAT) of Rs 748 crore in the October-December quarter of 2020-21 fiscal. Drug major Cipla on Tuesday reported a 2.6 per cent decline in its consolidated
Gains in Nifty Pharma were driven by industry major Cipla, which soared over 6 percent following its strong quarterly performance. The stock also happens to be the top gainer on the Nifty 50.